共 114 条
[1]
Lester RM(2019)QT assessment in early drug development: the long and the short of it Int J Mol Sci 20 1324-470
[2]
Paglialunga S(2018)QTc interval prolongation in critically ill patients: Prevalence, risk factors and associated medications PLoS ONE 13 e0199028-249
[3]
Johnson IA(2012)Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs: a prospective, observational study in a large urban academic medical center in the US Drug Saf 35 459-839
[4]
Fernandes FM(2013)Drug-drug interactions contributing to QT prolongation in cardiac intensive care units J Crit Care 28 243-234
[5]
Silva EP(2014)Corrected QT-interval prolongation and variability in intensive care patients J Crit Care 29 835-37
[6]
Martins RR(2019)Assessment of the risk of QT-interval prolongation associated with potential drug-drug interactions in patients admitted to Intensive Care Units Saudi Pharm J 27 229-246
[7]
Oliveira AG(2017)25 Years of proton pump inhibitors: a comprehensive review Gut and liver 11 27-139
[8]
Tisdale JE(2018)Proton pump inhibitors: review of emerging concerns Mayo Clinic Proc 93 240-1134
[9]
Wroblewski HA(2012)The risks of PPI therapy Nat Rev Gastroenterol Hepatol 9 132-556
[10]
Overholser BR(2018)Proton pump inhibitors: use and misuse in the clinical setting Expert Rev Clin Pharmacol 11 1123-413